Try our Advanced Search for more refined results
July 15, 2022
Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC
Case Number:
1:22-cv-00941
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
35:271 Patent Infringement
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
July 22, 2022
Drugmaker Says FDA Delayed OK Of Narcolepsy Medication
A drug developer is suing the U.S. Department of Health and Human Services over its yearlong delay in approving a newer and allegedly more efficient narcolepsy drug amid a fight over whether the drug would infringe one of the patents that protects Jazz Pharmaceuticals' billion-dollar grip on selling medications treating the condition.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login